T Cell Specific Surface Glycoprotein CD28 Market, Global Outlook and Forecast 2022-2028

T Cell Specific Surface Glycoprotein CD28 Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281569 | No. of Pages: 75 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of T Cell Specific Surface Glycoprotein CD28 in global, including the following market information:
Global T Cell Specific Surface Glycoprotein CD28 Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global T Cell Specific Surface Glycoprotein CD28 Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five T Cell Specific Surface Glycoprotein CD28 companies in 2021 (%)
The global T Cell Specific Surface Glycoprotein CD28 market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
FPT-155 Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of T Cell Specific Surface Glycoprotein CD28 include Atox Bio Ltd, Bristol-Myers Squibb Co, Five Prime Therapeutics Inc, Johnson & Johnson and TheraMAB LLC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the T Cell Specific Surface Glycoprotein CD28 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global T Cell Specific Surface Glycoprotein CD28 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global T Cell Specific Surface Glycoprotein CD28 Market Segment Percentages, by Type, 2021 (%)
    FPT-155
    FR-104
    Lulizumab Pegol
    Others
Global T Cell Specific Surface Glycoprotein CD28 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global T Cell Specific Surface Glycoprotein CD28 Market Segment Percentages, by Application, 2021 (%)
    Plaque Psoriasis
    Solid Tumor
    Acute Renal Failure(ARF)
    Others
Global T Cell Specific Surface Glycoprotein CD28 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global T Cell Specific Surface Glycoprotein CD28 Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies T Cell Specific Surface Glycoprotein CD28 revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies T Cell Specific Surface Glycoprotein CD28 revenues share in global market, 2021 (%)
Key companies T Cell Specific Surface Glycoprotein CD28 sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies T Cell Specific Surface Glycoprotein CD28 sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Atox Bio Ltd
    Bristol-Myers Squibb Co
    Five Prime Therapeutics Inc
    Johnson & Johnson
    TheraMAB LLC
1 Introduction to Research & Analysis Reports
    1.1 T Cell Specific Surface Glycoprotein CD28 Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global T Cell Specific Surface Glycoprotein CD28 Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global T Cell Specific Surface Glycoprotein CD28 Overall Market Size
    2.1 Global T Cell Specific Surface Glycoprotein CD28 Market Size: 2021 VS 2028
    2.2 Global T Cell Specific Surface Glycoprotein CD28 Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global T Cell Specific Surface Glycoprotein CD28 Sales: 2017-2028
3 Company Landscape
    3.1 Top T Cell Specific Surface Glycoprotein CD28 Players in Global Market
    3.2 Top Global T Cell Specific Surface Glycoprotein CD28 Companies Ranked by Revenue
    3.3 Global T Cell Specific Surface Glycoprotein CD28 Revenue by Companies
    3.4 Global T Cell Specific Surface Glycoprotein CD28 Sales by Companies
    3.5 Global T Cell Specific Surface Glycoprotein CD28 Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 T Cell Specific Surface Glycoprotein CD28 Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers T Cell Specific Surface Glycoprotein CD28 Product Type
    3.8 Tier 1, Tier 2 and Tier 3 T Cell Specific Surface Glycoprotein CD28 Players in Global Market
        3.8.1 List of Global Tier 1 T Cell Specific Surface Glycoprotein CD28 Companies
        3.8.2 List of Global Tier 2 and Tier 3 T Cell Specific Surface Glycoprotein CD28 Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global T Cell Specific Surface Glycoprotein CD28 Market Size Markets, 2021 & 2028
        4.1.2 FPT-155
        4.1.3 FR-104
        4.1.4 Lulizumab Pegol
        4.1.5 Others
    4.2 By Type - Global T Cell Specific Surface Glycoprotein CD28 Revenue & Forecasts
        4.2.1 By Type - Global T Cell Specific Surface Glycoprotein CD28 Revenue, 2017-2022
        4.2.2 By Type - Global T Cell Specific Surface Glycoprotein CD28 Revenue, 2023-2028
        4.2.3 By Type - Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share, 2017-2028
    4.3 By Type - Global T Cell Specific Surface Glycoprotein CD28 Sales & Forecasts
        4.3.1 By Type - Global T Cell Specific Surface Glycoprotein CD28 Sales, 2017-2022
        4.3.2 By Type - Global T Cell Specific Surface Glycoprotein CD28 Sales, 2023-2028
        4.3.3 By Type - Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share, 2017-2028
    4.4 By Type - Global T Cell Specific Surface Glycoprotein CD28 Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global T Cell Specific Surface Glycoprotein CD28 Market Size, 2021 & 2028
        5.1.2 Plaque Psoriasis
        5.1.3 Solid Tumor
        5.1.4 Acute Renal Failure(ARF)
        5.1.5 Others
    5.2 By Application - Global T Cell Specific Surface Glycoprotein CD28 Revenue & Forecasts
        5.2.1 By Application - Global T Cell Specific Surface Glycoprotein CD28 Revenue, 2017-2022
        5.2.2 By Application - Global T Cell Specific Surface Glycoprotein CD28 Revenue, 2023-2028
        5.2.3 By Application - Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share, 2017-2028
    5.3 By Application - Global T Cell Specific Surface Glycoprotein CD28 Sales & Forecasts
        5.3.1 By Application - Global T Cell Specific Surface Glycoprotein CD28 Sales, 2017-2022
        5.3.2 By Application - Global T Cell Specific Surface Glycoprotein CD28 Sales, 2023-2028
        5.3.3 By Application - Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share, 2017-2028
    5.4 By Application - Global T Cell Specific Surface Glycoprotein CD28 Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global T Cell Specific Surface Glycoprotein CD28 Market Size, 2021 & 2028
    6.2 By Region - Global T Cell Specific Surface Glycoprotein CD28 Revenue & Forecasts
        6.2.1 By Region - Global T Cell Specific Surface Glycoprotein CD28 Revenue, 2017-2022
        6.2.2 By Region - Global T Cell Specific Surface Glycoprotein CD28 Revenue, 2023-2028
        6.2.3 By Region - Global T Cell Specific Surface Glycoprotein CD28 Revenue Market Share, 2017-2028
    6.3 By Region - Global T Cell Specific Surface Glycoprotein CD28 Sales & Forecasts
        6.3.1 By Region - Global T Cell Specific Surface Glycoprotein CD28 Sales, 2017-2022
        6.3.2 By Region - Global T Cell Specific Surface Glycoprotein CD28 Sales, 2023-2028
        6.3.3 By Region - Global T Cell Specific Surface Glycoprotein CD28 Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America T Cell Specific Surface Glycoprotein CD28 Revenue, 2017-2028
        6.4.2 By Country - North America T Cell Specific Surface Glycoprotein CD28 Sales, 2017-2028
        6.4.3 US T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.4.4 Canada T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.4.5 Mexico T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe T Cell Specific Surface Glycoprotein CD28 Revenue, 2017-2028
        6.5.2 By Country - Europe T Cell Specific Surface Glycoprotein CD28 Sales, 2017-2028
        6.5.3 Germany T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.5.4 France T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.5.5 U.K. T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.5.6 Italy T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.5.7 Russia T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.5.8 Nordic Countries T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.5.9 Benelux T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia T Cell Specific Surface Glycoprotein CD28 Revenue, 2017-2028
        6.6.2 By Region - Asia T Cell Specific Surface Glycoprotein CD28 Sales, 2017-2028
        6.6.3 China T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.6.4 Japan T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.6.5 South Korea T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.6.6 Southeast Asia T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.6.7 India T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America T Cell Specific Surface Glycoprotein CD28 Revenue, 2017-2028
        6.7.2 By Country - South America T Cell Specific Surface Glycoprotein CD28 Sales, 2017-2028
        6.7.3 Brazil T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.7.4 Argentina T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa T Cell Specific Surface Glycoprotein CD28 Sales, 2017-2028
        6.8.3 Turkey T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.8.4 Israel T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.8.5 Saudi Arabia T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
        6.8.6 UAE T Cell Specific Surface Glycoprotein CD28 Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Atox Bio Ltd
        7.1.1 Atox Bio Ltd Corporate Summary
        7.1.2 Atox Bio Ltd Business Overview
        7.1.3 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Major Product Offerings
        7.1.4 Atox Bio Ltd T Cell Specific Surface Glycoprotein CD28 Sales and Revenue in Global (2017-2022)
        7.1.5 Atox Bio Ltd Key News
    7.2 Bristol-Myers Squibb Co
        7.2.1 Bristol-Myers Squibb Co Corporate Summary
        7.2.2 Bristol-Myers Squibb Co Business Overview
        7.2.3 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Major Product Offerings
        7.2.4 Bristol-Myers Squibb Co T Cell Specific Surface Glycoprotein CD28 Sales and Revenue in Global (2017-2022)
        7.2.5 Bristol-Myers Squibb Co Key News
    7.3 Five Prime Therapeutics Inc
        7.3.1 Five Prime Therapeutics Inc Corporate Summary
        7.3.2 Five Prime Therapeutics Inc Business Overview
        7.3.3 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Major Product Offerings
        7.3.4 Five Prime Therapeutics Inc T Cell Specific Surface Glycoprotein CD28 Sales and Revenue in Global (2017-2022)
        7.3.5 Five Prime Therapeutics Inc Key News
    7.4 Johnson & Johnson
        7.4.1 Johnson & Johnson Corporate Summary
        7.4.2 Johnson & Johnson Business Overview
        7.4.3 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Major Product Offerings
        7.4.4 Johnson & Johnson T Cell Specific Surface Glycoprotein CD28 Sales and Revenue in Global (2017-2022)
        7.4.5 Johnson & Johnson Key News
    7.5 TheraMAB LLC
        7.5.1 TheraMAB LLC Corporate Summary
        7.5.2 TheraMAB LLC Business Overview
        7.5.3 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Major Product Offerings
        7.5.4 TheraMAB LLC T Cell Specific Surface Glycoprotein CD28 Sales and Revenue in Global (2017-2022)
        7.5.5 TheraMAB LLC Key News
8 Global T Cell Specific Surface Glycoprotein CD28 Production Capacity, Analysis
    8.1 Global T Cell Specific Surface Glycoprotein CD28 Production Capacity, 2017-2028
    8.2 T Cell Specific Surface Glycoprotein CD28 Production Capacity of Key Manufacturers in Global Market
    8.3 Global T Cell Specific Surface Glycoprotein CD28 Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 T Cell Specific Surface Glycoprotein CD28 Supply Chain Analysis
    10.1 T Cell Specific Surface Glycoprotein CD28 Industry Value Chain
    10.2 T Cell Specific Surface Glycoprotein CD28 Upstream Market
    10.3 T Cell Specific Surface Glycoprotein CD28 Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 T Cell Specific Surface Glycoprotein CD28 Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com